Mismo tarro, tres precios

Tres cremas hidratantes con ceramidas

Qué le ofrece esta página: Si la marca compra algo y qué envase sale más barato para lo mismo.

La respuesta corta

Pruebe esto primero

Equate Moisturizing Cream

$3.42 por 100 g · 453 g tub

El mismo formato de tarro de 453 g a alrededor de la mitad del precio por 100 g.

Qué hacer después

Compre el que vaya a aplicar con generosidad y a menudo. Eso importa más que cuál de los tres elija.

Lo que esta página no puede decirle

Hidratar ayuda a la piel propensa al eccema, pero ningún ensayo muestra que una de estas cremas supere a otra.

Los tres productos

Los precios son una observación fechada, no una oferta vigente.

  1. Tarro de 453 g más barato

    Equate Moisturizing Cream

    $3.42 por 100 g453 g tub

    Ver la verificación de la fórmula (en inglés)

    Buscamos una lista de ingredientes publicada para este envase y no la encontramos · comprobado el 2026-08-23

    Label says unscented; the full ingredient list is not published on the listing.

    Fuente de fórmula comprobada ↗

  2. Mismo tamaño · alrededor del doble de precio

    CeraVe Moisturizing Cream

    $6.18 por 100 g453 g tub

    Ver la verificación de la fórmula (en inglés)

    Leímos la lista de ingredientes del envase de este mercado · comprobado el 2026-08-23

    A routine staple for us. The 539 g tub costs $29.97 — cheaper per gram.

    Fuente de la fórmula o etiqueta ↗

  3. Bálsamo con dosificador · vendido por volumen, no por peso

    La Roche-Posay Lipikar Balm AP+M

    $9.24 por 100 mL400 mL pump

    Ver la verificación de la fórmula (en inglés)

    Leímos la lista de ingredientes del envase de este mercado · comprobado el 2026-08-23

    Fragrance-free per the published ingredient list.

    Fuente de la fórmula o etiqueta ↗

Qué cambiaAmong the two 453 g tubs, Equate costs about half as much per 100 g; Lipikar is measured in mL and is not unit-ranked against them. Verification of the fragrance-free claim also differs.

Las verificaciones, lado a lado

One question per row. The green check marks that row's better answer — there is no overall winner.

Una verificación por fila, comparando Equate Moisturizing Cream, CeraVe Moisturizing Cream, La Roche-Posay Lipikar Balm AP+M.
VerificaciónEquateMoisturizing CreamCeraVeMoisturizing CreamLa Roche-PosayLipikar Balm AP+M
Proof one cream beats anotherindependent trials · Aug 20, 2026no reliable comparison identified in maintained sourcesno reliable comparison identified in maintained sourcesno reliable comparison identified in maintained sources
Fragrance-free?how well the claim can be checkedClaimedlabel says unscented; full list not publishedClaimedstated on the listingMejor respuesta de esta fila.Yes — verifiedno fragrance in the published list

Todo lo anterior en detalle: las verificaciones lado a lado, lo que halló cada estudio, lo que dicen las etiquetas y nuestras fuentes.

La evidencia detallada que sigue está escrita en inglés.

Por qué esta respuesta

Resumen de la comparación

Does the brand name buy anything?

Moisturizing itself helps eczema-prone skin — low-certainty trials show fewer flares — but the maintained evidence set through Aug 20, 2026 contains no trial showing that one of these creams beats another, ceramide branding included. We've kept CeraVe in the routine for years; the Equate tub is the same format at a bit over half the price. Buy whichever you'll use generously.

Qué coincide

All three are ceramide daily creams sold as fragrance-free or unscented, for dry or eczema-prone skin.

Qué cambia

Among the two 453 g tubs, Equate costs about half as much per 100 g; Lipikar is measured in mL and is not unit-ranked against them. Verification of the fragrance-free claim also differs.

Límite de la evidencia

Evidence on this page supports the ingredient, product type, or prevention step. It doesn't prove any one of these exact products is better.

Lo que los estudios encontraron de verdad

These three creams sit at three different levels in the maintained evidence set. One was studied by name and posted numbers, one is named in ClinicalTrials.gov records without posted results, and the ClinicalTrials.gov and PubMed searches identified no exact-product study for the third.

Our search found no study of this exact product

Equate Moisturizing Cream

The maintained ClinicalTrials.gov and PubMed searches returned no study record naming this cream as of August 20, 2026. At ingredient level, the closest work is a 20-patient randomized forearm-controlled study in which four drugstore moisturizers, including CeraVe Moisturizing Cream, were applied to one forearm and nothing to the other for four weeks: surface hydration improved, water loss through the skin did not change significantly, and the authors reported the study was underpowered. Those results were reported for the four moisturizers pooled together, so they attach to no single product, this one included.

Salvedad: Within the maintained PubMed results, the Equate name appears only as a brand keyword in a lactation-safety monograph, not in a record measuring whether a product works.

Tested by name, with published results

CeraVe Moisturizing Cream

A 528-person study at the University of Miami (NCT04724967) had adults with diabetes-related skin changes use CeraVe Hydrating Cleanser and CeraVe Moisturizing Cream twice a day for 28 days, and posted results on 22 September 2022. At day 33 a physician graded 447 of the 528 much or very much improved, 72 improved, 9 unchanged, and none worse. There was one group and no comparison: nobody used a different cream or no cream, nobody was kept unaware of what they were using, and CeraVe was named as the study's industry partner.

Salvedad: A doctor who knew what everyone was using, grading a single group with nothing to compare against, cannot separate the cream from time, from washing, or from expectation.

~Only older Lipikar formulas have published results

La Roche-Posay Lipikar Balm AP+M

Registered studies do name Lipikar Baume AP+M, the French label for this balm, and the largest followed 4,631 adults (NCT05765461) — but it is an observational cohort run by L'Oreal's own subsidiary Cosmetique Active International, with no control group, and it has posted no results. The only Lipikar records that posted results tested other formulas and both stopped early: Lipikar Balm AP, the earlier formula without the +M, ended with 2 people enrolled (NCT01577628), and an earlier Lipikar Baume ended at 73 because patients were improving on their own with the weather (NCT00931411).

Salvedad: AP+ and AP+M are different formulas, and the maintained ClinicalTrials.gov search returned no record using the retail name Balm AP+M, so the match to this 400 mL balm rests on the French Baume labeling.

Only one of these three creams has been measured by name in a study that posted numbers, and that study had one group and no control. The maintained ClinicalTrials.gov and PubMed searches identified no comparison among the three and no result showing that one works better than another as of August 20, 2026.

Cómo buscamos estudios sobre estos productos exactos

Última búsqueda:

For each evidence row, search the quoted evidence-row product name, then the quoted brand plus the distinctive product-name tokens. A brand-wide statement additionally requires a quoted brand-name search. Formula codes are added only when an official or study source discloses them.

  • ClinicalTrials.gov: Registered studies returned by exact product-name, brand-plus-product-name, and disclosed internal formula-code searches.
  • PubMed: Indexed records returned by exact product-name and brand-plus-distinctive-product-token searches.

Lo que esto no le dice: A negative maintained search is a dated coverage statement, not proof that no study exists in another database, language, registry, sponsor archive, unpublished report, or differently named formula.

Notas y fuentes
  1. Moisturizing works: a 2017 Cochrane review (77 trials) found that people using moisturizer had flares less than half as often, and needed less steroid cream — mostly low-certainty evidence. Its exact words: "We did not find reliable evidence that one moisturiser is better than another."
  2. Ceramide branding has no independent win: a 2023 double-blind trial in 53 children found a ceramide cream no better than a plain paraffin cream on eczema scores.
  3. Our eczema evidence index tracks 5 registered moisturizer studies, 3 with posted results — evidence about the ingredient type, not these tubs.
  4. The Equate tub's full ingredient list is not published on its listing; "unscented" is the label claim. CeraVe's fragrance-free claim is stated on its listing; La Roche-Posay's was verified against its published list.
  5. Prices seen Aug 20, 2026; none flagged as a sale. CeraVe also sells a 539 g tub at $29.97 — a better per-gram price than the 453 g compared here. The two tubs can be compared per 100 g; Lipikar is labelled in mL and is shown separately because no product density was available.
  6. ClinicalTrials.gov and PubMed searches through Aug 20, 2026 identified no head-to-head study of these exact products.

Después de la evidencia

Ver precios actuales en Amazon

Como afiliado de Amazon, Skinlogie obtiene ingresos por compras que cumplen los requisitos, sin costo adicional para usted. Los enlaces llevan a fichas exactas cuando están verificadas.

  • CeraVe Moisturizing Cream453 g tub
  • La Roche-Posay Lipikar Balm AP+M400 mL pump